REPRIEVE Trial

Thanks to lifesaving drugs, people with HIV are proudly achieving aging milestones. Now, researchers have been searching for ways to keep this community healthier in their later years. Read more in The New York Times: https://www.nytimes.com/2023/09/10/health/hiv-aging-statins.html
AIDS Clinical Trials Group National Heart, Lung, and Blood Institute (NHLBI) National Institute of Allergy and Infectious Diseases (NIAID)

The REPRIEVE Trial is excited to be sharing some preliminary baseline findings at CROI 2021! If you're attending virtual CROI this year, be sure to check out these 4 Science Spotlight presentations from the REPRIEVE team:

National HIV/AIDS & Aging Awareness Day reminds us that although ART has been successful at prolonging the lives of , people aging with HIV often experience a number of other comorbidities - which is why findings from will be so important